Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India

AIM: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. To control the spread, a mass vaccination program is initiated. Antibody titer after vaccination can be a better marker to monitor immunological resp...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Mukesh Kumar, Richa Singh, Abhishek Kamendu, Amit Kumar Singh, Jyoti Sangwan
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Wolters Kluwer Medknow Publications 2022-01-01
Цуврал:	Indian Journal of Health Sciences and Biomedical Research KLEU
Нөхцлүүд:	2019 novel coronavirus coronavirus disease 2019 novel coronavirus pneumonia severe acute respiratory syndrome coronavirus 2
Онлайн хандалт:	http://www.ijournalhs.org/article.asp?issn=2542-6214;year=2022;volume=15;issue=3;spage=256;epage=260;aulast=Kumar
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!